Dr. Maria Baiulescu, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 540 Litchfield Street, Charlotte Hungerford Hosp Mso, Torrington, CT 06790 Phone: 860-796-6340 Fax: 860-482-8627 |
Mrs. Elzbieta A Lach-pasko, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 540 Litchfield St, Charlotte Hungerford Hospital Mso, Torrington, CT 06790 Phone: 860-496-6340 Fax: 860-482-8627 |
Dr. Michele P. Normandin, MD Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 245 Alvord Park Rd, Bldg B, Torrington, CT 06790 Phone: 860-496-0455 Fax: 860-496-2793 |
News Archive
A multidisciplinary research team at Case Western Reserve University led by Gary Landreth, Ph.D., a professor in the School of Medicine's Department of Neurosciences, has uncovered a common genetic pathway for a number of birth defects that affect the development of the heart and head.
A team of investigators from the Broad Institute, Massachusetts General Hospital and other leading biomedical research institutions has pinpointed rare mutations in a gene called APOA5 that increase a person's risk of having a heart attack early in life. These mutations disable the APOA5 gene and also raise the levels in the blood of triglyceride-rich lipoproteins, a type of fat.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal.
Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments today at the Clinical Laboratory Improvement Advisory Committee meeting.
MP Biomedicals LLC announced today that it has received approval of its investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to start pivotal clinical trials in the USA with the MP Diagnostics™ HTLV-I/II ELISA 4.0 and HTLV Blot.2.4. Studies will be conducted within the American Red Cross, the California Department of Public Health, and LABS, Inc. The company is working closely with the principal investigator of the American Red Cross sites, Dr. Susan Stramer, Executive Scientific Officer.
› Verified 6 days ago